Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights
In cystic fibrosis (CF), mutations in the cystic fibrosis transmembrane conductance regulator (<i>CFTR</i>) gene disrupt the capacity of the encoded protein to function as a channel to transport chloride ions and water across cell membranes. The consequences are deleterious, system-wide,...
Main Authors: | Justin E. Ideozu, Xi Zhang, Susanna McColley, Hara Levy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/10/3/180 |
Similar Items
-
Transcriptional consequences of impaired immune cell responses induced by cystic fibrosis plasma characterized via dual RNA sequencing
by: Justin E. Ideozu, et al.
Published: (2019-05-01) -
The Staphylococcus aureus Transcriptome during Cystic Fibrosis Lung Infection
by: Carolyn B. Ibberson, et al.
Published: (2019-11-01) -
Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis
by: Justin E. Ideozu, et al.
Published: (2017-08-01) -
Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease
by: Matthew D. Strub, et al.
Published: (2020-05-01) -
CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
by: Katherine B. Hisert, et al.
Published: (2020-08-01)